All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Structure of Bovine CD46 Ectodomain

Aitkenhead H. et al, (2023), Viruses, 15, 1424 - 1424

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.

Ragonnet-Cronin M. et al, (2023), Nat Commun, 14

Accelerating drug target inhibitor discovery with a deep generative foundation model.

Chenthamarakshan V. et al, (2023), Science advances, 9

Broadly neutralizing antibodies against COVID-19.

Zhou D. et al, (2023), Current opinion in virology, 61

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface

Zhang P. et al, (2023)

Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer.

Pei X. et al, (2023), Nature communications, 14

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.

Wei J. et al, (2023), Nature communications, 14

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.

Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Leclerc QJ. et al, (2021), BMC Health Services Research, 21

Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections

Eyre DW. et al, (2021), BMC Infectious Diseases, 21

Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.

Redhead MA. et al, (2021), Scientific reports, 11

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Russell CD. et al, (2021), The Lancet Microbe, 2, e354 - e365

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Docherty AB. et al, (2021), The Lancet Respiratory Medicine, 9, 773 - 785

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Drake TM. et al, (2021), The Lancet, 398, 223 - 237

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

Drake TM. et al, (2021), The Lancet Rheumatology, 3, e498 - e506

Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort

Yates T. et al, (2021), Obesity, 29, 1223 - 1230

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Bloom CI. et al, (2021), The Lancet Respiratory Medicine, 9, 699 - 711

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Gupta RK. et al, (2021), The Lancet Respiratory Medicine, 9, 349 - 359

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Lumley SF. et al, (2021), New England Journal of Medicine, 384, 533 - 540

Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10

Zhao Y. et al, (2020), Nature Communications, 11

Cookies on this website

All Publications